|
|
Article: Senate proposes new powers, funds for FDA inspections of drug and device facilities.(Food & Drug)
- Article from:
- Inspection Monitor
- Article date:
- May 1, 2009
CopyrightCOPYRIGHT 2009 Washington Information Source, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
A revived safety proposal in the U.S. Senate would give regulators new funding and authority to inspect plants that make prescription drugs and medical devices, Bloomberg reported April 23.
Legislation introduced by Senators Charles Grassley (R-IA) and Edward Kennedy (D-MA) would empower FDA to collect inspection fees from companies and issue subpoenas or detain products when inspectors believe a product is adulterated or misbranded. The measure is similar to one introduced last year by the senators.
Lawmakers faulted FDA's lack of inspections last year after contaminated heparin from China was tied to hundreds of deaths and allergic reactions. The ...